Contributions of PuffRemoverPax

Contributions by PuffRemoverPax, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 444 edits includes activity predating the current log.

1. 14:00, 5 Jun 2026 (diff | hist) Talk:C-peptide 748 +84 /* Measured on treatment */ reply
2. 03:31, 2 Jun 2026 (diff | hist) Purity claim inflation 5,660 ±0 m space between number and unit per PP:MOS
3. 11:33, 18 Apr 2026 (diff | hist) Talk:Peptide stability table 1,307 +246 /* RfC: should the table give a −20 °C default for research powders? */ reply
4. 11:20, 8 Mar 2026 (diff | hist) Talk:Beta cell function 537 +179 /* The word "restores" */ new section
5. 13:15, 27 Feb 2026 (diff | hist) Talk:Receptor bias 611 +101 /* Productive research, disappointing translation */ reply
6. 17:54, 6 Feb 2026 (diff | hist) Drug master file 4,325 ±0 clarify that personal importation and commercial importation are different questions
7. 09:50, 6 Feb 2026 (diff | hist) Talk:Liraglutide 674 +153 /* Should the article say liraglutide is obsolete? */ new section
8. 11:18, 16 Oct 2025 (diff | hist) Melanotan II 4,649 +275 m add category for the peptide class
9. 11:30, 10 Oct 2025 (diff | hist) Talk:Chinese Peptide Company 1,170 +63 /* The water-figure observation — are we praising a supplier? */ reply
10. 13:05, 8 Oct 2025 (diff | hist) Talk:Chinese Peptide Company 537 +213 /* The water-figure observation — are we praising a supplier? */ new section
11. 10:44, 15 Aug 2025 (diff | hist) Janoshik Analytical 5,235 ±0 expand §What the reports contain
12. 10:18, 27 Jun 2025 (diff | hist) Talk:Trial data comparison 1,170 +100 /* Should the bars be there at all? */ reply
13. 11:07, 24 Jun 2025 (diff | hist) Talk:Trial data comparison 537 +203 /* Should the bars be there at all? */ new section
14. 10:02, 13 Jun 2025 (diff | hist) Talk:Zhuhai Kerui Biotechnology 1,033 +81 /* Method disclosure: are we writing an endorsement? */ reply
15. 11:48, 10 Jun 2025 (diff | hist) Talk:Zhuhai Kerui Biotechnology 400 +174 /* Method disclosure: are we writing an endorsement? */ new section
16. 10:40, 30 Apr 2025 (diff | hist) Talk:Qingdao Sigma Chemical 1,170 +109 /* Reporting a tally count without implying a ranking */ reply
17. 10:04, 10 Apr 2025 (diff | hist) Talk:Wuhan Wansheng Biotechnology 1,244 +217 /* RfC: what does a large report set actually support? */ reply
18. 19:24, 12 Jan 2025 (diff | hist) Contraindications of incretin therapy 2,653 ±0 m add the note that titration exists partly to manage these effects
19. 11:14, 7 Dec 2024 (diff | hist) Talk:GL Biochem (Shanghai) 1,033 +181 /* Supporter disclosure and article neutrality */ reply
20. 01:43, 18 Nov 2024 (diff | hist) Methionine oxidation 2,072 +656 m add the figure for the chromatogram and caption its axes
21. 13:36, 28 Oct 2024 (diff | hist) Missed dose 3,110 +1,081 add the dead-space volume to the worked example